Trends in Lung Cancer: The Incidence and Mortality Rate in India
Binson V A1, M Subramoniam2, Sania Thomas3

1Binson V A, Research Scholar, Department of Electronics Engineering, Sathyabama Institute of Science and Technology, Chennai (Tamil Nadu), India.
2Dr. M Subramoniam, Associate Professor, Department of Electronics Engineering, Sathyabama Institute of Science and Technology, Chennai (Tamil Nadu), India.
3Sania Thomas, Assistant Professor, Department of Computer Science & Engineering, Saintgits College of Engineering, Kottayam (Tamil Nadu), India.

Manuscript received on 18 June 2019 | Revised Manuscript received on 25 June 2019 | Manuscript published on 30 June 2019 | PP: 1956-1962 | Volume-8 Issue-5, June 2019 | Retrieval Number: E7617068519/19©BEIESP
Open Access | Ethics and Policies | Cite | Mendeley | Indexing and Abstracting
© The Authors. Blue Eyes Intelligence Engineering and Sciences Publication (BEIESP). This is an open access article under the CC-BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Abstract: The curative treatment of lung cancer is more difficult as most of the cases are diagnosed at its later stage. In developing countries like India, the incidence rate and death rate of lung cancer is increasing year by year. Globally lung cancer is the leading cause of cancer death in comparison with other common cancers like prostate, cervical, breast, colon and skin cancer. In India the root cause of lung cancer are the consumption of tobacco based products and the smoked percentage of these products are Beedi (28.4% to 79%), Cigarette (9.0% to 53.7%), Hooka (3.4% to 77.3%) and mixed (7.5% to 13.6%). In 2016 out of total 8.87 million global cancer deaths, lung cancer have the major share with 1.71 million deaths and in India it have the second major share with 69601 deaths from a total 796,235 deaths. In every nine minutes one Indian expires of Lung Cancer whereas in every eight minutes, one Indian is detected with Lung Cancer.
Keywords: Death Rate, India, Incidence Rate, Lung Cancer, PBCR.

Scope of the Article: Biomedical Computing